Suchergebnisse - "Hicks, David G"

PubPharm (238)

1

In ER-Positive, HER2-Negative Breast Cancers, HER2 mRNA Levels Correlate Better with Clinicopathologic Features and Oncotype DX Recurrence Score than HER2 Immunohistochemistry

enthalten in: Laboratory investigation; a journal of technical methods and pathology | 2024

von Tyburski, H. | Karakas, C. | Finkelman, B. | +3

2

HER2 evaluation for clinical decision making in human solid tumours : pearls and pitfalls

enthalten in: Histopathology | 2024

von Zhang, H. | Finkelman, B. | Ettel, M. | +3

3

Validation and interpretation of Pan-TRK immunohistochemistry : a practical approach and challenges with interpretation

enthalten in: Diagnostic pathology | 2024

von Karakas, C. | Giampoli, E. | Love, T. | +2

4

Emerging Landscape of Targeted Therapy of Breast Cancers With Low Human Epidermal Growth Factor Receptor 2 Protein Expression

enthalten in: Archives of pathology & laboratory medicine | 2024

von Tozbikian, G. | Krishnamurthy, S. | Bui, M. | +7

5

HER2 categorical changes after neoadjuvant chemotherapy : A study of 192 matched breast cancers with the inclusion of HER2-Low category

enthalten in: Human pathology | 2023

von Karakas, C. | Tyburski, H. | Turner, B. | +6

6

Analytical and clinical validation of PATHWAY Anti-HER-2/neu (4B5) antibody to assess HER2-low status for trastuzumab deruxtecan treatment in breast cancer

enthalten in: Virchows Archiv : an international journal of pathology | 2023

von Garrido, C. | Manoogian, M. | Ghambire, D. | +19

7

HER2 in uterine serous carcinoma : Current state and clinical perspectives

enthalten in: American journal of clinical pathology | 2023

von Navarro Sanchez, J. | Finkelman, B. | Turner, B. | +7

8

Interobserver and Interantibody Reproducibility of HER2 Immunohistochemical Scoring in an Enriched HER2-Low-Expressing Breast Cancer Cohort

enthalten in: American journal of clinical pathology | 2023

von Karakas, C. | Tyburski, H. | Turner, B. | +5

9

The Rochester Modified Magee Algorithm (RoMMa) : An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing

enthalten in: Cancers | 2023

von Turner, B. | Finkelman, B. | Hicks, D. | +10

10

The Evolution of Ki-67 and Breast Carcinoma : Past Observations, Present Directions, and Future Considerations

enthalten in: Cancers | 2023

von Finkelman, B. | Zhang, H. | Hicks, D. | +1

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[24]